Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$498M |
| 2 |
Micron Technology
MU
|
$374M |
| 3 |
Amazon
AMZN
|
$356M |
| 4 |
Accenture
ACN
|
$318M |
| 5 |
Advanced Micro Devices
AMD
|
$301M |
Top Sells
| 1 |
Apple
AAPL
|
$684M |
| 2 |
Meta Platforms (Facebook)
META
|
$630M |
| 3 |
Tesla
TSLA
|
$595M |
| 4 |
Chevron
CVX
|
$497M |
| 5 |
Shopify
SHOP
|
$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Norwegian Cruise Line
NCLH
$11.6B
| – | – |
-149,100
| Closed | -$1.66M |
|
4327
National CineMedia
NCMI
$411M
| – | – |
-4,510
| Closed | -$41K |
|
4328
NCS Multistage Holdings
NCSM
$111M
| – | – |
-10,426
| Closed | -$323K |
|
4329
Intellia Therapeutics
NTLA
$1.29B
| – | – |
-119,600
| Closed | -$6.19M |
|
|
NTST
4330
NETSTREIT Corp
NTST
$1.72B
| – | – |
-77,600
| Closed | -$1.46M |
|
4331
Nucor
NUE
$33.8B
| – | – |
-73,300
| Closed | -$7.65M |
|
4332
NovoCure
NVCR
$1.37B
| – | – |
-18,386
| Closed | -$1.28M |
|
4333
Envista
NVST
$3.54B
| – | – |
-62,800
| Closed | -$2.42M |
|
|
NVX
4334
NOVONIX
NVX
$210M
| – | – |
-10,499
| Closed | -$69K |
|
4335
NatWest
NWG
$55.4B
| – | – |
-75,586
| Closed | -$444K |
|
4336
Northwest Natural Holdings
NWN
$1.71B
| – | – |
-20,400
| Closed | -$1.08M |
|
4337
Realty Income
O
$54.2B
| – | – |
-24,900
| Closed | -$1.7M |
|
4338
Ocugen
OCGN
$322M
| – | – |
-621,856
| Closed | -$1.41M |
|
4339
ONE Gas
OGS
$4.56B
| – | – |
-20,600
| Closed | -$1.67M |
|
4340
OLB
OLB
$9.82M
| – | – |
-12,250
| Closed | -$108K |
|
4341
Ollie's Bargain Outlet
OLLI
$8.18B
| – | – |
-359,500
| Closed | -$21.1M |
|
4342
Omeros
OMER
$284M
| – | – |
-540,400
| Closed | -$1.49M |
|
4343
Oracle
ORCL
$654B
| – | – |
-1,395,232
| Closed | -$97.5M |
|
4344
Oramed Pharmaceuticals
ORMP
$91.4M
| – | – |
-359,697
| Closed | -$1.65M |
|
|
OTRK
4345
DELISTED
Ontrak
OTRK
| – | – |
-746
| Closed | -$71K |
|
4346
Outfront Media
OUT
$3.05B
| – | – |
-1,143,175
| Closed | -$19.1M |
|
4347
Occidental Petroleum
OXY
$45.2B
| – | – |
-118,444
| Closed | -$6.97M |
|
4348
Belpointe PREP
OZ
$243M
| – | – |
-3,500
| Closed | -$342K |
|
4349
Pacific Biosciences
PACB
$381M
| – | – |
-114,200
| Closed | -$505K |
|
4350
Invesco WilderHill Clean Energy ETF
PBW
$357M
| – | – |
-5,000
| Closed | -$229K |
|